Researchers at Rutgers Robert Wood Johnson Medical School have reported the first instance of COVID-19 triggering a recurrence of Guillain–Barré Syndrome – a rare disorder where the body’s immune system attacks nerves and can lead to respiratory failure and death. While there have been several reports of Guillain–Barré Syndrome following COVID-19, this is the first in which COVID-19 actually triggered a recurrence of the condition – in a 54-year-old man who had suffered with Guillain–Barré Syndrome twice and had a third occurrence after testing positive for COVID-19, according to the Rutgers case report published in the journal Pathogens. To read the full story.
Home / News / Rutgers Reports First Instance of COVID-19 Triggering Recurrent Guillain-Barré Syndrome
Recent Posts
- Study Finds Widespread Exposure to Hormone-Disrupting Chemical During Pregnancy.
- Community-Based Programs in Senior Centers May Lower Health Care Use and Costs for People with Dementia
- New NJACTS Publication
- How Rutgers Health and Vaccine Equity Education Coalition Ambassadors at the Boys & Girls Club of Newark Are Promoting Vaccine Equity.
- Center for Environmental Exposures and Disease 7th Annual Environmental Health and Justice Summit 10/18, 9am-4pm
Categories
- Community (2,020)
- Covid (975)
- CTO Events (3)
- News (2,570)
- Pilots (20)